The association between breast cancer and other extra-mammary neoplasms, particularly colorectal carcinoma, is well established.' This, coupled with the presence of some similar epidemiological features in the two tumours, suggest that there may be a common aetiological factor.2 In this context some investigators have recently reported the presence of oestrogen receptors in up to 30% of colorectal carcinomas,34 and the possibility that these tumours may be influenced by appropriate endocrine manipulation has been raised. 5 The scientific literature, however, also contains reports of studies which failed to show the presence of oestrogen receptors in colorectal cancer. 6 7 This discrepancy, together with the recent introduction of monoclonal antibodies that can be used for assessing the oestrogen content." 12 All our colorectal tumours were of the usual adenocarcinoma type. None was of the much less common pure mucinous or of the rare signet ring adenocarcinoma type, and the oestrogen receptor content of these uncommon varieties may therefore be different.
Another possibility is that the specific epitopes recognised by the monoclonal antibodies used in two of the assays are not present in the oestrogen receptor of colorectal carcinomas as these monoclonal antibodies are produced specifically for the detection of oestrogen receptor in breast and female genital tract tissue. This seems unlikely as the same two monoclonal antibodies have been reported to be used for the demonstration of oestrogen receptor content in gastric adenocarcinoma.
"
The ligand binding assay has also been used successfully for the demonstration of oestrogen receptor in other tissues, such as stomach'3 and prostate, '4 as well as in one of our colonic tumours (case 22).
It is concluded that most colorectal adenocarcinomas of the usual type, in both sexes, are oestrogen receptor negative, although an occasional case may show unimportant concentrations of the receptor protein. It therefore seems unlikely that endocrine manipulations would have an influence on the course of these tumours.
